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Abstract
One of the fundamental questions of enzymology is how catalytic power is derived. This review
focuses on recent developments in the structure-function relationships of chorismate-utilizing
enzymes involved in siderophore biosynthesis to provide insight into the biocatalysis of pericyclic
reactions. Specifically, salicylate synthesis by the two-enzyme pathway in Pseudomonas
aeruginosa is examined. The isochorismate-pyruvate lyase is discussed in the context of its
homologues, the chorismate mutases, and the isochorismate synthase is compared to its
homologues in the MST-family (menaquinone, siderophore or tryptophan biosynthesis) of
enzymes. The tentative conclusion is that the activities observed cannot be reconciled by
inspection of the active site participants alone. Instead, individual activities must arise from unique
dynamic properties of each enzyme that are tuned to promote specific chemistries.
Siderophores are low molecular weight iron chelators produced by bacteria, fungi and
plants, which scavenge iron from the environment, and are frequently required for virulence
in pathogenic bacteria (1, 2). The isochorismate synthase (PchA) and isochorismate-
pyruvate lyase (PchB) from Pseudomonas aeurginosa are involved in the synthesis of the
siderophore pyochelin (3, 4). PchA converts chorismate to isochorismate which PchB in turn
uses to produce salicylate by elimination of pyruvate. These enzymes will be used as the
basis for a discussion of enzymatically-catalyzed pericyclic reactions. It is useful to consider
these enzymes in the reverse order of the biosynthetic pathway.
Reactions Catalyzed by PchB
PchB catalyzes chiefly the pericyclic reaction of Figure 1A. A pericyclic reaction is a
concerted one in which a closed, cyclic flow of electrons (curved arrows) leads from bound
reactants to bound products. For PchB, the reaction is a concerted but asynchronous [1,5]-
sigmatropic shift with a quantitative hydrogen transfer from C2 to C9 as detected by NMR
(5) and confirmed computationally (6), with an observed kcat/Km of 4.11×104 M−1s−1 (7).
Interestingly, PchB can also perform a nonphysiological role as a chorismate mutase (Figure
1B), albeit with considerably lower catalytic efficiency (3) (kcat/Km = 1.96×102 M−1s−1 (7)).
This reaction, also pericyclic, is a Claisen rearrangement of chorismate to prephenate in
which the concerted but asynchronous [3,3]-sigmatropic shift transfers the pyruvate tail
from the C3 ether linkage to a C1–C9 linkage (8). Therefore, PchB catalyzes two pericyclic
reactions, which are unusual in biology.
Pericyclic reactions are attractive for study as examples of fundamental enzyme theory since
the reaction catalyzed does not require direct contribution from the enzyme. For example, no
protons or electrons are donated or accepted from the enzyme or cofactors, nor are there
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covalent intermediates. Instead, the binding event leads to organization of the substrate into
the transitions state thereby resulting in product formation. However, this also means that
pericyclic reactions present problems for use of many traditional ideas about enzyme
catalysis, since the concepts from acid-base, metal-ion and covalent catalysis do not apply.
Electrostatic stabilization is also problematic: the reactions are concerted in the sense that
there are no intermediate compounds formed, but the cyclic electron distribution of the
transition state is still an unsettled issue; i.e. the charge distribution in the transition state
may be debatable. Nevertheless, the enzymes that perform these reactions, especially the
chorismate mutases, have been studied in detail to develop fundamental ideas of transition
state theory and more generally catalysis.
PchB is a structural homolog of the AroQ chorismate mutases
Sequence similarity (20%) between PchB and the chorismate mutases of the AroQ structural
class led to the hypothesis that PchB is a structural homologue of E. coli chorismate mutase
(EcCM) (3). Three structures of wildtype PchB have been published (9, 10) and these
indicate that PchB is indeed a structural homologue of EcCM (Figure 2). In the structure of
EcCM, an oxabicyclic transition state analogue is held in place by interaction with a total of
eight charged/polar amino acids (11). In PchB, however, only five of those amino acids are
conserved, and the decreased number of hydrogen bonds and ionic interactions may lead to
known promiscuity of this enzyme and the ability to catalyze both the lyase and mutase
reactions (Figure 3) (10). There is a major structural difference between the apo-form and
the pyruvate-bound or the pyruvate-and-salicylate-bound forms of PchB: the active site loop
between helix one and helix two is disordered in the apo-structure but fully ordered in the
ligand-bound structures. A difference between the open and closed structures is due to a
conserved active site lysine (residue 42, green in Figure 3) which hydrogen bonds to a
bound pyruvate molecule. These structures may represent an open state for substrate or
product entry and egress and a closed catalytic state (10).
Structures of the chorismate mutases
The chorismate mutases of the AroQ class, such as EcCM, comprise an intertwined dimer
composed of three helices (Figure 2). The two equivalent active sites per dimer are buried,
and formed from amino acids from both monomers. In the only EcCM structure determined,
a transition state analogue (TSA) is aligned in the active site by interaction of its
carboxylates with arginines, one from each monomer (11). A debate has arisen in the field
about how EcCM (kcat/Km of 2.4×105 M−1s−1, (12)) derives its catalytic power, and this
debate has consistently cited work on the chorismate mutase from Bacillus subtilis (BsCM;
kcat/Km of 1×106 M−1s−1 (13)). The data derived from EcCM and BsCM are sometimes
compared directly even though the proteins are not structurally homologous. BsCM, an
AroH chorismate mutase, is a trimer that forms a pseudo α/β-barrel with active sites at the
interfaces between the monomers (Figure 2). The structure of BsCM has been determined
apo-, with prephenate-bound, and with TSA-bound (14–16); however, there is little
difference in the active sites of the three structures. In BsCM, the product/TSA is oriented in
the active site by comparable arginines to those in the EcCM. Again, the active sites of
EcCM and BsCM are usually considered comparable due to their shape and charge
complementarity (17).
Hilvert and colleagues have developed a monomeric AroQ chorismate mutase by inserting
an eight amino acid hinge-loop sequence into helix one, which allows this helix to fold over
to form a shortened coiled-coil that is the structural basis of the protein and also allows for
completion of the active site (18–20). This engineered monomeric Methanococcus
jannaschii chorismate mutase (mMjCM) has comparable kinetic parameters (kcat/Km of 1.9
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× 104 M−1s−1) to that of the wildtype MjCM (kcat/Km of 6.4 × 104 M−1s−1) and the EcCM
under similar conditions (kcat/Km of 3.0 × 104 M−1s−1) (18). Yet, mMjCM is molten globule
in the absence of ligand, but forms the structure seen in Figure 2 in the presence of the
oxabicyclic transition state analogue (19, 20).
Chorismate mutases: catalytic power
One hypothesis to explain how chorismate mutases derive their catalytic power is
electrostatic transition state stabilization (TSS). Considerable biochemical data support this
hypothesis, and indicate that a positively charged amino acid (Lys39 in EcCM, Arg90 in
BsCM) stabilizes the developing negative charge during bond breaking at the ether oxygen
(8, 12, 13, 21–23). Mutational analysis in EcCM (Lys39) and BsCM (Arg90) have
determined this site to be critical for catalysis (12, 13). The conservative change in BsCM of
Arg90 to a citrulline (isoteric but neutral) or to lysine (similarly positively charged),
decreases the catalytic efficiency by at least three orders of magnitude, whereas deletion of
the sidechain (R90A) led to a complete abolition of activity (13, 23). Similar mutations in
EcCM (for example, K39A) lead to a decrease in kcat/Km of five orders of magnitude (12). A
critique of the mutagenesis work in the chorismate mutases is that mutagenesis at this lysine
in EcCM alters the active site to an extent that the absence or presence of a positively
charged amino acid at this site is immaterial (24). The evidence for this comes from a
shoulder at ~210 nm in the circular dichroism spectra (12).
A second hypothesis has a basis in quantum mechanical/molecular mechanical molecular
dynamics simulations (QM/MM-MD): formation of a near attack conformation (NAC) (24–
29). A NAC is defined as a structure in which the reacting atoms are within van der Waals
contact distance and approach at an angle ±15° to the bond that is formed, or an orientation
in which the π-orbitals overlap (Figure 1) (25, 27). While a NAC is a “turnstile” through
which reactants pass on the way to the transition state (27), once a NAC is formed, the
reaction occurs spontaneously without further electrostatic stabilization or steric strain (24–
27, 29). Interestingly, the mutase reaction and elimination of the enolpyruvyl sidechain are
both observed in the uncatalyzed reaction (30, 31). However, the elimination reaction is not
catalyzed by the chorismate mutase enzymes. Therefore, formation of the NAC for the
Claisen rearrangement does not lead to the transition state for the elimination reaction (27).
In other words, in an aqueous environment, it is possible to form a variety of NACs that
proceed through different transition states to produce different products. Chorismate mutases
limit the type of NACs formed, and catalysis proceeds through a particular transition state to
form the desired product. In this model, formation of the reactive conformation of the
substrate is the prerequisite for the enzyme to be a catalyst (24–27, 29).
QM/MM calculations at very high levels of QM theory have found that catalysis is due to a
combination of transition state stabilization and conformational effects for BsCM (32). The
substrate binds in the active site as a NAC according to all proposed definitions, but
formation of this bound conformation is not the sole source of catalytic power. Instead, a
combination of binding the reactive conformation and electrostatic transition state
stabilization provides the decrease in the energy barrier for catalysis (33–35). Recent
benchmark calculations by Dr. Mulholland's group using high-level ab initio QM/MM
methods give results in excellent agreement with experiment for the activation enthalpies
and free energies of the BsCM reaction (32).
Catalysis by the PchB is dependent on the 42 site
Whereas it is likely that PchB will perform the mutase reaction using a mechanism similar to
that seen for its structural homologue EcCM, it is unlikely that PchB will use the same
mechanism to perform the physiologically important lyase reaction. More to the point, the
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two reactions must have differing near attack conformations and/or transition states (Figure
1), suggesting differing reaction mechanisms. Mutational analysis of PchB has led to insight
into the alternative reaction mechanisms for the two reactions catalyzed by this enzyme (7).
Importantly, mutation of the lysine at the 42 position (green in Figure 3) that is comparable
to the lysine hypothesized to be important in electrostatic transition state stabilization in
EcCM did not lead to structural perturbation of the active site. Evidence for this is provided
in the form of circular dichroism data (7), and also the x-ray structures of the K42A (7) and
K42E (9) mutants. However, K42A-PchB showed 1% of WT mutase and lyase activities,
whereas the K42E mutant had no detectible activity for either reaction (7). Furthermore,
examination of the effects of a variety of active site variants provides experimental evidence
in agreement with the QM/MM calculations that suggest that neither a reactive substrate
conformation nor electrostatic transition state stabilization completely accounts for kcat of
the rate-determining step for the two catalyzed reactions (7).
An intriguing result comes from pH profiles of the K42H mutant: kcat is titrated with
changing pH indicating that a positive charge at the 42 is necessary for efficient catalysis. It
should be noted that this variant form retains the ability to catalyze the lyase reaction when
the sidechain is deprotonated (~100-fold decrease in kcat/KM), indicating that the enzyme is
a sufficient catalyst even without this sidechain charge (9). A calculation of an experimental
ΔΔG‡ by comparing the mutational effect at low and high pH gives a value of 2.4 kcal/mol
for electrostatic transition state stabilization at the 42 site. Temperature dependence of kcat
experiments indicate the difference in ΔΔG‡ between the uncatalyzed and enzyme-catalyzed
lyase reaction is 7.43 kcal/mol, and there is a large entropic penalty for the transition from
the enzyme-substrate complex to the transition state (36). One plausible explanation is that
loop closing occurs after the initial binding event and may, with the positively charged
amino acid at the 42 site, drive the formation of the transition state. This is in agreement
with the pre-steady state kinetic experiments for mMjCM which indicate that
conformational ordering is on the same timescale as catalysis, suggesting that
conformational plasticity is linked to efficient enzymatic catalysis (19).
PchB is unusual in siderophore biosynthesis
Several bacterial species incorporate salicylate into their siderophores (Figure 4). The
formation of yersiniabactin by Yersinia enterocolitica and mycobactin by Mycobacterium
tuberculosis requires the conversion of chorismate to salicylate which is accomplished by a
single enzyme (Irp9 and MbtI, respectively) in a single active site (37–40) (Figure 5). The
salicylate synthases convert chorismate to salicylate via the formation of an isochorismate
intermediate by general acid/general base catalysis, followed by a pericyclic reaction to
generate salicylate, which is analogous to that catalyzed by PchB. The isochorismate
synthases from Escherichia coli (EntC and MenF) and Pseudomonas aeruginosa (PchA) are
homologues of the salicylate synthases (41–43). PchA produces isochorismate for
conversion to salicylate by PchB and incorporation into the pyochelin siderophore. EntC is
part of the enterobactin biosynthetic pathway, forming a dihydroxybenzoate-capped
siderophore (44, 45) and MenF produces isochorismate as the first step in the biosynthesis of
the electron carrier menaquinone (46). Whereas these enzymes are hypothesized to perform
analogous general acid/general base chemistry to produce isochorismate as observed for
MbtI and Irp9, they do not perform the pericyclic reaction to produce salicylate. This means
that PchA, MenF and EntC cannot perform any pericyclic reactions despite homology to
enzymes that can: Irp9 and MbtI. Most intriguingly, the two bi-functional enzymes do not
have a PchB-like domain, but are able to perform the lyase activity with the structurally and
functionally homologous domain found in MenF and EntC.
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Structures of the enzymes that synthesize isochorismate (MST enzymes)
The x-ray crystallographic structures of four enzymes that isomerize chorismate to
isochorismate have been determined (37, 38, 40–43). Irp9, MbtI, MenF and EntC are
structural homologues (PchA awaits structure determination for confirmation of this
hypothesis), with an α-β fold first described for the TrpE subdomian of anthranilate synthase
(Figure 6) (47). These enzymes belong to a family of enzymes involved in menaquinone,
siderophore or tryptophan biosynthesis and collectively have been named the MST family
(40). The catalytic mechanism for isomerization of the chorismate ring has been determined
through the cumulative work of several groups by structural and mutational analyses (38, 40,
41). A Mg2+ ion in the active site orients the C1 carboxyl group of chorismate. A lysine
residue serves as a general base for the activation of water to attack at the C2 carbon, and a
glutamic acid is a general acid for elimination of the C4-OH (Table 1 and Figure 7).
However, recent work by Ziebart and Toney indicates that activation of water as a
nucleophile may not be solely attributable to Lys147/205 of EntC/MbtI as K→Q mutations
retained some activity (48). The catalytic mechanism for conversion of isochorismate to
salicylate by MbtI has been shown to be a sigmatropic, pericyclic mechanism by analogous
experiments to those described above for PchB (40). This reaction is pH dependent,
occurring only at pH values 7.5 and greater (40). Chorismate mutase activity has also been
detected in MbtI with a kcat/Km value approximately one third that of the salicylate synthase
activity, using protein purified in two different ways, using a histidine-tag or an intein-
chitin-tag (40). In these experiments, whereas salicylate synthase activity is Mg2+
dependent, the chorismate mutase activity was only detected when the Mg2+ was not present
in the wildtype active site. MbtI has also been purified with a histidine tag and a second ion
exchange step to produce a sample that has reduced or no detectable chorismate mutase
activity, and the authors suggest that the mutase activity is the result of a contaminant (48).
Keeping in mind the contrary evidence, MbtI may perform two pericyclic reactions. If so,
the active site must be altered by the removal of the Mg2+ cofactor for the adventitious
chorismate mutase catalysis, implying differing binding modes for the chorismate which
lead to differing reactive substrate conformations and/or transition states and thus different
products.
Presumably, the homologues that are lyase-active salicylate synthases must have structural
features that the lyase-deficient isochorismate synthases do not. Whether this would be an
amino acid for electrostatic stabilization of the transition state or an active site that selects
for or arranges the substrate into a near attack conformation is still an open question. A close
examination of the active sites leads to the startling realization that all but three of the amino
acids are strictly conserved (Table 1 and Figure 7). First, EntC has a phenylalanine in place
of a tyrosine (all other homologues) at one location in the active site (residue 327). Mutation
at this site decreased isochorismate synthase activity by more than an order of magnitude,
but did not lead to detectable salicylate production (43). Second, the backbone carbonyl of
T348 in Irp9 H-bonds to the salicylate-OH, and this amino acid is conserved in MbtI. The
transition of this amino acid from Thr to Ala is a conserved change for the enzymes that are
lyase deficient (MenF, EntC and PchA). It has been proposed that this amino acid is
responsible for the differences in activities of the two groups of enzymes (lyase-active and
lyase-deficient). However, mutation of A to T at this site in both MenF (41) and EntC (43)
did not convert these enzymes to lyase-active: neither variant enzyme produced salicylate
and both showed significant decreases in their physiological isochorismate synthase activity.
Finally, a trend can also be detected between lyase-active and lyase-deficient homologues at
a residue that chelates the Mg2+ through a water molecule. In Irp9 and MbtI, the lyase-active
enzymes, this amino acid is a glutamic acid (E281 and E294, respectively; see Table 1).
However, the lyase-deficient homologues (MenF, EntC, and PchA) all have an amino acid
that is one methylene group shorter, either an aspartic acid (EntC and PchA) or an
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asparagine (MenF). This site has largely been ignored in the literature, probably because of
its distance from the site of chemistry. Nevertheless, as shown in the stereo diagram (Figure
7), this difference in sidechain length may cause a shift in the binding of the Mg2+ and thus
select for the products formed in the active site. It is tempting to propose that this shift may
result in the inability to make a reactive substrate conformation in the lyase-deficient
enzymes, but this hypothesis awaits testing.
Alternate reaction pathways and the free-energy landscape
In this paper, we have discussed three of the folds that catalyze two pericyclic reactions and
the analysis illustrates that sequence and structural homology do not correlate to catalytic
predictability: 1) structural homologues with strong sequence conservation at the active site
may or may not have pyruvate-lyase activity (the salicylate and isochorismate synthases), 2)
structural homologues with low conservation of active site residues catalyze one or two
pericyclic reactions (E. coli chorismate mutase and the isochorismate-pyruvate lyase;
respectively), and 3) enzymes with differing folds perform the same chemistry (E. coli and
B. subtilis chorismate mutases). The pericyclic reactions catalyzed in this discussion are
single substrate, and require no participation from the enzyme in the form of general acid-
general base chemistry, metal ion catalysis (the Mg2+ of the MST enzymes are structural,
orienting the substrate), or a covalent intermediate. Let us assume that the requirements for
an active site that efficiently catalyzes one or more pericyclic reactions are: the ability to
force the substrate into a reactive conformation with the pyruvylenol tail over the ring, and/
or to have a strategically placed positive amino acid to stabilize the developing negative
charge of the transition state. In other words, the ability of the different enzymes to perform
zero, one or two pericyclic reactions may be conferred by simple positional interaction
strategies. However, many changes to the first and second tier amino acids of the active sites
of these enzymes have been made rationally and by directed evolution with minimal success
(43, 49, 50) strongly suggesting that simple structural correlations are insufficient to account
for the observed chemistries.
The laboratory-evolved mMjCM which orders upon ligand binding (18–20) is suggestive of
the idea that catalytic power may be derived from the ability of these enzyme active sites to
develop a “catalytic network” as described by Benkovic, Hammes and Hammes-Schiffer
(51). While these authors weren’t considering protein folding from a molten globule, they do
suggest that catalysis must be considered in the context of protein motion, including large
conformational modes such as changes elicited by binding of ligands and vibrational modes
on the timescale of catalysis (51). A three dimensional free energy landscape with many
possible alternate reaction paths which are occupied by multiple sequential intermediates
allow for the generally similar yet subtly different active sites to be (or not to be) catalysts.
The differing pathways traveled by the substrate-enzyme ensemble along the mountain
ranges of the free energy landscape may require differing relative contributions of the near
attack conformation or electrostatic transition state stabilization.
Abbreviations and Full Textual Notes
AroH protein family with sequence homology to chorismate mutases with α/β-
barrel fold
AroQ protein family with sequence homology to chorismate mutases with all α-
helical fold
BsCM Bacillus subtilis chorismate mutase
EcCM E. coli chorismate mutase
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EntC isochorismate synthase from E. coli
Irp9 salicylate synthase from Yersinia enterocolitica
NAC near attack conformation
MbtI salicylate synthase from Mycobacterium tuberculosis
MenF isochorismate synthase from E. coli
mMjCM laboratory derived monomeric chorismate mutase from Methanococcus
jannaschii
MST protein family containing proteins of menaquinone, siderophore or
tryptophan biosynthesis
PchA isochorismate synthase from Pseudomonas aeruginosa
PchB isochorismate-pyruvate lyase from Pseudomonas aeruginosa
QM/MM-MD quantum mechanical/molecular mechanical molecular dynamics
simulations
TS transition state
TSA transition state analogue
TSS transition state stabilization
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Figure 1. Pericyclic reactions catalyzed by PchB
A. Isochorismate-pyruvate lyase: hydrogen transfer from C2 to C9 concerted with pyruvate
elimination. B. Chorismate mutase: C-C bond formation between C1 and C9 concerted with
C-O bond fission between C3 and the ether oxygen.
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Figure 2. Structure of PchB, E. coli chorismate mutase, monomeric Methanococcus jannaschii
chorismate mutase and B. subtilis chorismate mutase
The PchB dimer is show in red and tan with salicylate and pyruvate shown in green sticks
(PDB code: 3REM). The EcCM dimer is red and gold with the oxabicyclic transition state
analogue (TSA) in green sticks (PDB code: 1ECM). The mMjCM monomer is shown in
yellow with the inserted intrahelical turn shown in red and the TSA in green (PDB code:
2GTV). The BsCM timer is red, yellow and magenta with the TSA in green (PDB code:
2CHS).
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Figure 3. Stereo image comparing the active site of PchB and EcCM
The arginines that align the carboxylates of the substrate are shown in pink, and the lysine
hypothesized to be important in the transition state stabilization theory is show in green. The
ligands are shown in cyan: salicylate and pyruvate in the PchB structure and TSA in the
EcCM structure. In all cases, the lighter shades are PchB and darker are EcCM. Amino acids
are labeled as PchB numbering/EcCM numbering.
Lamb Page 13













Figure 4. Biosynthetic products
All of the above compounds require the conversion of chorismate to isochorismate as a part
of their biosynthesis. The portion of the compound that is derived from the isochorismate is
shown in bold. Mycobactin, yersiniabactin and pyochelin are salicylate-capped
siderophores. Enterobactin is also a siderophore, capped by di-hydroxybenzoate.
Menaquinone is an electron carrier and a form of Vitamin K.
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Figure 5. Reactions catalyzed by isochorismate and salicylate synthases
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Figure 6. Structures of the salicylate synthases (Irp9 and MbtI) and isochorismate synthases
(MenF and EntC)
The domains of these monomeric proteins are shown as blue and yellow. Mg2+, if in
determined structures, are shown as gray spheres. (PDB codes: Irp9 – 2FN1, MbtI – 2I6Y,
MenF – 2BZM, EntC – 3HWO).
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Figure 7. Stereo image comparing the active sites of Irp9 and EntC
The general acid/general base residues are show in green, and Mg2+ is shown as a sphere.
Non-conserved residues are pink. Ligands are show in in cyan: salicylate and pyruvate in the
Irp9 structure and isochorismate of the EntC structure. In all cases, the lighter shades are
EntC and darker are Irp9. Amino acids are labeled as Irp9 numbering/EntC numbering.
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